Evaluating RISQ System Implementation in Acutely Malnourished Children in Chad (CRIMSON)

Sponsor
The Hospital for Sick Children (Other)
Overall Status
Recruiting
CT.gov ID
NCT06123390
Collaborator
Alliance for International Medical Action (Other), University of N'Djaména, Chad (Other)
20,000
1
2
13.7
1463.3

Study Details

Study Description

Brief Summary

The purpose of this study is to evaluate the effect of the Responses to Illness Severity Quantification (RISQ) system implementation on mortality and processes of care in a nutritional program treating children 6 to 59 months of age with acute malnutrition in Ngouri, Chad.

Condition or Disease Intervention/Treatment Phase
  • Other: The Responses to Illness Severity Quantification (RISQ) System
N/A

Detailed Description

The CRIMSON Study is a 12-month cluster randomized trial that will evaluate the effect of implementing the RISQ system compared with usual care on all-cause mortality, in children with acute malnutrition aged 6 to 59 months enrolled in the OptiMA nutrition program in Chad.

The intervention is the RISQ System and the clusters are the individual health centres that are randomized with a ratio of 1:1, RISQ System: Usual care. The 12 month intervention period will begin following a run in phase in which sites randomized to intervention will introduce and establish the new practices and in which sites randomized to usual care will continue to provide usual care.

The RISQ system is a scientifically developed clinical decision support tool that consists of: [1] the RISQ score; [2] documentation form; [3] score-matched recommendations and [4] an implementation package. The RISQ score, developed through our prospective observational study in Maiduguri Nigeria ((NCT04582773) ranges from 0 to 26 (high scores indicating greatest severity of illness). In the development dataset, the mean RISQ score on admission was 3.6 in hospital survivors and 7.3 for children dying <48hr of admission. RISQ scores <24hr before death had Area Under the Receiver Operating Characteristics Curve (AUROC) of 0.93. The RISQ score performed similarly well in children independent of their clinical conditions as a diagnosis-independent measure of severity of illness. Additionally, through a study of 903 hospitalized children with Severe Acute Malnutrition (SAM), the RISQ score could discriminate between points of escalation or de-escalation of care and can reflect illness severity in children throughout hospitalization. The documentation form provides visual representation of the sub-scores of each RISQ score items and guidance for score calculation. The score-matched recommendations of the RISQ system that are linked to the RISQ scores are derived from an expert panel of clinicians, with over 100 years of collective experience caring for acutely malnourished children, and provide guidance about intensity of care. This includes the frequency of observation, consideration of secondary review, inpatient admission, and transfer into / out of inpatient care areas where more intensive treatments are provided.The implementation package consists of theoretical and practical training modules including specific 'train the trainers' sessions for key personal involved in the implementing programs.

The CRIMSON study is nested within the existing framework of the OptiMA nutritional program and observational study conducted by the Alliance for International Medical Action (ALIMA). The program involves health centres within Ngouri, a sub-prefecture of the Lake Region in Chad (and surrounding area) plus an inpatient unit at the Ngouri District Hospital providing care for children with acute malnutrition. Inclusion criteria for the OptiMA program are based on mid-upper arm circumference (MUAC) of <125mm and/or bilateral pitting oedema. Usual care in the OptiMA program is as follows: nutritional treatment to participants consists of Ready-to-use-Therapeutic Food (RUTF) adjusted based on their MUAC value throughout the duration of their care. Management of the children with acute illnesses follows the established approach for management of children with severe acute malnutrition using the World Health Organization (WHO) "danger signs" and Integrated Management of Childhood Illness (IMCI) algorithms to guide admission to hospital. Additionally, as part of the OptiMA program in Ngouri, pulse oximeters have been introduced in all health centres and inpatient care unit, following training by ALIMA. Included in the routine visits of the program is the measurement and documentation of each of the 7 RISQ score items [heart rate, respiratory rate, respiratory effort, oxygen saturation, temperature, level of consciousness and oxygen use (oxygen is currently only available in the inpatient care)] by nurses.

The investigators anticipate that implementation of the RISQ system in a nutrition treatment program will improve sensitivity and specificity of clinical evaluation in determining which children require hospitalization, and what level of medical care within the in-patient unit is appropriate and in turn potentially reduce mortality.

Study Design

Study Type:
Interventional
Anticipated Enrollment :
20000 participants
Allocation:
Randomized
Intervention Model:
Parallel Assignment
Intervention Model Description:
In this study we are evaluating usual care (Arm 1) vs. the Responses to Illness Severity Quantification (Arm 2) in children children aged 6 to 59 months who are enrolled in the OptiMA nutrition program in Chad. Community health centres will be the randomized clusters.In this study we are evaluating usual care (Arm 1) vs. the Responses to Illness Severity Quantification (Arm 2) in children children aged 6 to 59 months who are enrolled in the OptiMA nutrition program in Chad. Community health centres will be the randomized clusters.
Masking:
Single (Outcomes Assessor)
Masking Description:
The participants and care providers will know which arm of the study they are part of, as the randomization occurs at the facility level. Only the statistician will be blinded to the arms at the time of analysis.
Primary Purpose:
Supportive Care
Official Title:
Cluster-Randomized Trial of the Implementation of the Responses to Illness Severity Quantification System (RISQ) in Children With Acute Malnutrition Six to Fifty-nine Months of Age in Ngouri, Chad
Actual Study Start Date :
Sep 11, 2023
Anticipated Primary Completion Date :
Aug 31, 2024
Anticipated Study Completion Date :
Oct 31, 2024

Arms and Interventions

Arm Intervention/Treatment
No Intervention: Usual Care

The 17 health centres randomized to "Usual Care" will provide care as per OptiMA program.

Experimental: Intervention Arm

The 17 health centres randomized to the intervention arm will provide care as per OptiMA program with the addition of the RISQ System decision support.

Other: The Responses to Illness Severity Quantification (RISQ) System
The RISQ System involves: [1] the RISQ score: calculated routinely using the [2] documentation record and linked to [3] score-matched recommendations. Introduction into clinical care is supported by [4] the RISQ System implementation package. During the 2 month prior to implementation, front-line staff in the intervention arm will be trained on and will practice the use of the RISQ System .

Outcome Measures

Primary Outcome Measures

  1. All-cause mortality. [12 months]

    Mortality over the period beginning at admission to the program and ending at either program discharge or to a maximum of 60 days after study enrolment. Program discharge will be one of: [1] medical/anthropometric criteria or [2] defaulting from the program. Defaulting from the program is defined as children who do not attend the weekly clinic visits for 3 consecutive weeks.

Secondary Outcome Measures

  1. Timing of inpatient mortality [Duration of hospitalization in days up to 60 days]

    Timing will be defined as [a] within 48 hours of hospital admission and [b] timing of death after admission to hospital

  2. Timing of outpatient mortality [Duration of program inclusion in days up to 60 days]

    Timing will be defined as [a] within 48 hours of being seen by health-care team [b] timing of death after being seen by outpatient health-care team

  3. Therapeutic intensity [First 24 hours from admission to hospital]

    To be measured by location on admission to inpatient care (Intensive Care Unit/Phase1/Phase2)

  4. Efficiency of inpatient care [Duration of hospitalization in days up to 60 days]

    Efficiency measured by length of inpatient stay (whole or part days)

  5. Workload [Month 1 and month 12]

    Frontline staff perception of workload measured through questionnaires using a 5 point scale

  6. Knowledge [Month 1 and month 12]

    Frontline staff knowledge of assessment skills measured through questionnaire using a 5 point scale

  7. Fidelity of RISQ Implementation [12 months]

    Number of measured vital signs performed on individual patient at health centre visit with corresponding disposition in program, recorded in 10 randomly selected patients/week/health centre

  8. Acceptability [Month 1 and month 12]

    Acceptability of the RISQ System by front-line staff evaluated through a questionnaire using a 5 point scale

Other Outcome Measures

  1. Lived experience of RISQ System implementation [one time at end of 12 month implementation period]

    Lived experiences measured by open ended questions about strengths/weaknesses of RISQ System implementation added to frontline staff perception questionnaire at end of intervention period

  2. comparison of automated versus manual measurements of vital signs (Respiratory rate in breaths/min) [During run-in phase prior to implementation of intervention, on average 2 months]

    Comparison determined by agreement between the two different methods for respiratory rate measurement

  3. comparison of automated versus manual measurements of vital signs (Temperature in degrees Celsius) [During run-in phase prior to implementation of intervention, on average 2 months]

    Comparison determined by agreement between the two different methods for temperature measurement

  4. Comparison of RISQ scores among children with different clinical conditions in inpatient care [Duration of hospitalization in days up to 60 days]

    Differences in RISQ scores among children with different clinical diagnoses a) on admission to inpatient care; b) throughout inpatient care; and c) at exit from inpatient care

Eligibility Criteria

Criteria

Ages Eligible for Study:
6 Months to 59 Months
Sexes Eligible for Study:
All
Accepts Healthy Volunteers:
No
Inclusion Criteria:
Children:
  1. age: 6 to 59 months at enrolment on the day of their admission/re-admission to the OptiMA program

  2. written consent to participate

Front line staff providing care to patients enrolled in the Optima program:

[1] Registered Nurses [2] Medical Doctors

Exclusion Criteria:
Children:
  1. Children allergic to milk, peanuts and/or ready-to-use therapeutic food (RUTF)

  2. Children not residing in one of the study areas.

Contacts and Locations

Locations

Site City State Country Postal Code
1 Ngouri Ngouri Chad

Sponsors and Collaborators

  • The Hospital for Sick Children
  • Alliance for International Medical Action
  • University of N'Djaména, Chad

Investigators

  • Principal Investigator: Christopher Parshuram, MD, PhD, The Hospital for Sick Children

Study Documents (Full-Text)

None provided.

More Information

Additional Information:

Publications

Responsible Party:
Christopher Parshuram, Staff Physician, Paediatric Intensive Care Unit, Department of Critical Care Medicine, The Hospital for Sick Children
ClinicalTrials.gov Identifier:
NCT06123390
Other Study ID Numbers:
  • 1000080735
First Posted:
Nov 8, 2023
Last Update Posted:
Nov 14, 2023
Last Verified:
Nov 1, 2023
Individual Participant Data (IPD) Sharing Statement:
No
Plan to Share IPD:
No
Studies a U.S. FDA-regulated Drug Product:
No
Studies a U.S. FDA-regulated Device Product:
No
Keywords provided by Christopher Parshuram, Staff Physician, Paediatric Intensive Care Unit, Department of Critical Care Medicine, The Hospital for Sick Children
Additional relevant MeSH terms:

Study Results

No Results Posted as of Nov 14, 2023